SCHEMBL3490972

SCHEMBL3490972

C=C[C]([Si](C)(C)C)[Si](C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3056449 0.67
SCHEMBL5369837 0.65
SCHEMBL1421603 0.65
SCHEMBL14855 0.61
SCHEMBL20661241 0.61 ALDH1A1 (1.00) ALDH1A1TP53TSHR
SCHEMBL1331930 0.61
SCHEMBL322832 0.61 ALDH1A1 (1.00) ALDH1A1TP53TSHR
SCHEMBL31707460 0.59 ALDH1A1 (0.41) ALDH1A1TP53TSHR
SCHEMBL7091146 0.58
Bromide SCHEMBL8198603 0.58 ALDH1A1 (0.91) ALDH1A1TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9447127-B2 Synthetic lung surfactant and use thereof UNIVERSITY OF ROCHESTER (US) 2016-09-20 US disclosed
US-20140044775-A1 SYNTHETIC LUNG SURFACTANT AND USE THEREOF UNIVERSITY OF ROCHESTER (US) 2014-02-13 US disclosed
US-8563683-B2 Synthetic lung surfactant and use thereof UNIVERSITY OF ROCHESTER (US) 2013-10-22 US disclosed
US-20100055164-A1 SYNTHETIC LUNG SURFACTANT AND USE THEREOF UNIVERSITY OF ROCHESTER (US) 2010-03-04 US disclosed
EP-2049554-A2 SYNTHETIC LUNG SURFACTANT AND USE THEREOF University of Rochester Medical Center (US) 2009-04-22 EP disclosed
EP-1985619-A1 Isospecific styrene polymerisation TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2008-10-29 EP disclosed
WO-2008011559-A2 SYNTHETIC LUNG SURFACTANT AND USE THEREOF UNIVERSITY OF ROCHESTER (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100055164-A1 SYNTHETIC LUNG SURFACTANT AND USE THEREOF PHOSPHO1, SGMS1, SMPD1 ALDH1A1 4759/4885TP53 2234/4885TSHR 2303/4885
US-20140044775-A1 SYNTHETIC LUNG SURFACTANT AND USE THEREOF PHOSPHO1, SGMS1, SMPD1 ALDH1A1 4759/4885TP53 2234/4885TSHR 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.